Immunis, Inc., a clinical-stage biotechnology company developing first-in-class multi-active biologics for muscle health and ...
9h
Regenerative Medicine Market worth $62.69 billion by 2031 - Exclusive Report by MarketsandMarkets™
According to MarketsandMarkets™, the Regenerative Medicine Market is projected to reach USD 62.69 billion by 2031 from USD 23.90 billion in 2026, at a CAGR of 21.3% during the forecast period.
Spain-based low/mid-market investor, Buenavista Equity Partners, has acquired 71.2% stake in Tiryaq Medical Group, a Spanish ...
Collaboration supports Armenia's growing demand for clinically backed, physician-dispensed skincare.
A conference in Edmond is uniting farmers, physicians and wellness experts to promote healthier communities through ...
The first time Arun Sharma, PhD, turned human stem cells into beating heart cells, he was an undergraduate on a summer ...
LionhearTV on MSN
Philippine Society for Regenerative Medicine pushes for science-based treatments and patient safety ahead of first annual convention
During a press conference held on October 13, PSRM President Dr. Quincy P. Raya and Dr. Daryl Joel C. Dumdum met with members ...
Under the Advanced Regenerative Medicine treatment plan launched in September, ViGenCell's immune cell therapy VT-EBV-N will ...
Before joining Alliance Orthopedics, Dr. Cartagena spent two years working in a high-volume private practice setting, ...
AV Laboratories is joining Regenivus at The Aesthetic & Regenerative Medicine Conference, taking place on 18–19 October at ...
Autologous bone marrow-derived mesenchymal stem cell therapy for spinal cord injury.Its achievements and the connection to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results